Davis Jennifer L. 4
4 · PROCTER & GAMBLE Co · Filed Dec 20, 2024
Insider Transaction Report
Form 4
Davis Jennifer L.
CEO - Health Care
Transactions
- Tax Payment
Common Stock
2024-12-19$169.79/sh−46.27$7,856→ 52,917.702 total - Award
Restricted Stock Units
2024-11-15+21.683→ 157.726 total→ Common Stock (21.683 underlying) - Exercise/Conversion
Restricted Stock Units
2024-12-19−46.27→ 736.73 total→ Common Stock (46.27 underlying) - Exercise/Conversion
Common Stock
2024-12-19$169.79/sh+46.27$7,856→ 52,963.972 total
Holdings
- 14,610.872(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
- [F2]Shares withheld to cover taxes on previous Restricted Stock Unit grant.
- [F3]Reflects adjustment to PST through September 30, 2024.
- [F4]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
- [F5]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
- [F6]Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2024.